Document is current
Any future updates will be listed below
-
Authors
Ronczka, J https://orcid.org/0009-0000-2751-4763
von Bonin, S
Laubner, A
Hochauf-Stange, K
Rank, M
Kolditz, M https://orcid.org/0009-0009-5367-7932
-
Funding
Funding for this research was provided by:
Technische Universität Dresden
- License Information
-
More Information
Article History
Received: 7 January 2025
Accepted: 3 March 2025
First Online: 17 March 2025
Declarations
:
: Not applicable.
: JR has received support from AstraZeneca to attend a conference. MK reports payment or honoraria for lectures from AstraZeneca, Berlin-Chemie, Boehringer Ingelheim, Gilead, GSK, Insmed, Pfizer; and participation in advisory boards for AstraZeneca, Gilead, GSK, MSD, and Insmed; all outside of the submitted work.SvB, KHS, AL and MR do not have conflicts of interest to report.
: The study was approved by the ethics committee of the TU Dresden (BO-EK-161042023) and waiver of informed consent was granted. The study was registered with the German Clinical Trials Register (“Deutsches Register Klinischer Studien” – DRKS) under the number DRKS00032559.
